Changes
in Oxygen
Tension
and Effects
on
Cyclooxygenase
Metabolites:
III. Decrease
of
Retinal
Prostacyclin
in Kittens
Exposed
to
Hyperoxia
Marie J. Stuart, MD, Dale L. Phelps, MD, and B. N. Yamaja Setty, PhD
From the Division of Pediatric Hematology-Oncology, Department of Pediatrics, State University of New York Health Science Center, Syracuse, and the Department of Pediatrics and Ophthalmology, University of Rochester School of Medicine and Dentistry, Rochester, New York
ABSTRACT. The acute phase of oxygen-induced retinop-athy is associated with vasoconstriction and occlusion of the retinal vessels. Because this acute vasoobliterative phase could be due to the inhibition in retinal vessels of the production of the potent vasodilator and antithrom-botic metabolite prostacyclin, animal experiments were performed to assess this possibility. Eight litters of 27 kittens (four to six days of age) were used. Control kittens
were left in room air; hyperoxic kittens were placed in
80% oxygen for 48 hours; recovery kittens were returned to room air for 24 hours following hyperoxic exposure. Following treatments, the animals were killed, retinas isolated, and prostaglandin formation assessed. Retinal tissues produced 6-keto-prostaglandin F,, prostaglandin F2a, prostaglandin E2, and thromboxane B, from exoge-nous arachidonate. A significant (approximately 33%) reduction in retinal 6-keto-prostaglandin Fia (the end product of prostacyclin) was observed both in the
hyper-oxic and recovery litter mates when compared with
con-trols. Both of the experimental groups also demonstrated a reduction in total retinal prostanoids that paralleled the changes observed in prostacyclin, suggesting that the biochemical effect of hyperoxia on retinal vascular ara-chidonic acid metabolism occurred at the level of cycloox-ygenase. A decrease in the local production of prostacy-din during hyperoxia is consistent with the histologic retinal changes observed during the acute phase of oxy-gen-induced retinopathy. Pediatrics 1988;82:367-372; cy-clooxygenase metabolites, retinal prostacyclin, hyperoxia.
ABBREVIATIONS. NDGA, nordihydroguaiaretic acid; 6-keto-PGF1a, 6-keto-prostaglandin F,; PGF2a, prostaglandin F,; PGE2, prostaglandin E2; TXB2, thromboxane B2; PGD2, prosta-glandin D2.
Received for publication June 1, 1987; accepted Oct 14, 1987. Reprint requests to (M.J.S.) Division of Hematology-Oncology, St Christopher’s Hospital for Children, 5th and Lehigh Aye, Philadelphia, PA 19133
PEDIATRICS (ISSN 0031 4005). Copyright © 1988 by the American Academy of Pediatrics.
Retinopathy of prematurity develops only in
in-fants whose retinal vessels are immature. Although
it has occurred in some infants without the
admin-istration of supplemental oxygen, the majority of
cases develop in premature infants who have re-ceived oxygen for prolonged periods.”2 Additionally,
it has been recognized since the 1950s that the
prolonged use of 50% inspired oxygen without
ad-justment according to the infant’s need causes the incidence of this disorder to increase significantly.3
In the animal model, the acute phase of
oxygen-induced retinopathy is associated with morphologic
alterations of the retinal vascular intima, and
vaso-constriction and occlusion of the vascular lumen in
both arterioles and capillaries.4’5 Because
prosta-cyclin produced by normal blood vessel
endothe-hum is a potent vasodilator and inhibitor of
vas-cular thrombus formation,6 we had previously
hy-pothesized that the pathologic changes observed
during the acute phase of oxygen-induced
retinop-athy might result from an inhibition of the
forma-tion of this potent vasoactive mediator.7 Using
hu-man umbilical vessels in an in vitro study, we
demonstrated that short-term hyperoxic exposure
resulted in the decreased ability of vessels to
pro-duce prostacyclin.7 A logical extension ofthis initial
work would be to translate these in vitro
observa-tions into an in vivo animal study and, moreover, to evaluate the specific microvasculature of inter-est, namely, the retina. In this study, we
demon-strated that prostacyclin production is reduced in
the partially vascularized retina of kittens exposed
to hyperoxia. Retinal prostacyclin was also found
to be decreased in kittens 24 hours into the recovery
phase following an initial period of hyperoxia.
80 60 40 z Ui >-0
I 2 3 4 5 6 7
AGE IN DAYS
Fig 1. Study design. Time periods during which control
( ), hyperoxic (- - - -), and recovery animals
(#{149}#{149})
were exposed to 21% and 80% oxygen aregraphically illustrated.
retinal changes observed during the acute phase of
oxygen-induced retinopathy.
MATERIALS AND METHODS
Pregnant queens were obtained from a specific
pathogen-free colony of laboratory cats and housed
individually. The animals were observed daily, and
the day when kittens were first discovered was
defined as day 1. The kittens were then numbered
and randomly assigned to either control, hyperoxia,
or recovery groups. As shown in Fig 1, control
animals stayed continuously in room air. Hyperoxic
animals were placed in 80% inspired oxygen for 48
hours before removal of their eyes. The recovery
kittens were placed in 80% inspired oxygen for 48
hours, after which the animals were removed to
room air for an additional 24-hour period prior to
removing the eyes for evaluation of prostaglandin
metabolite formation. Thus, as shown in Fig 1, the
hyperoxic group was placed in 80% inspired oxygen
one day later than the recovery animals. This study
design ensured that all animals within the
individ-ual litters were at similar postnatal ages when all
litter mates were killed. A total of 27 kittens from
eight litters were used, and the retinal tissues were
obtained at the ages of six to eight days of life.
Thus, the time at which retinal cyclooxygenase
products were assessed varied between the sixth
and eighth postnatal day but remained constant
within each experiment. Oxygen was provided at a
minimum flow of 10 L/min in standard infant
incubators to prevent carbon dioxide accumulation.
The mother cat provided all nutrition for the
kit-tens and was rotated between the two halves of her
litter at 12-hour intervals.
In other studies, arterial blood gas values were
determined on heparinized blood obtained by left
ventricular puncture from three- to six-day-old
kit-- - - I-1YPER0XI
I-,
I#{149}
, .
, .
,
I
#{149}_.RECOVERY - - CONTR0Ltens who were in either 80% oxygen (n = 20) or
room air (n = 8).
All retinal tissues from a single litter were
ob-tamed on the same day and analyzed together. The
animals were anesthetized with intraperitoneal
bar-biturate, the aorta was canalized and ligated
dis-tally, and the cerebral vasculature was perfused
with warmed isotonic saline until the effluent from
the jugular veins was essentially clear. The time
required to reach this condition averaged
approxi-mately seven minutes following euthanasia. The
eyes were then enucleated, the vitreous, retina, and
choroid were carefully separated under a dissecting
microscope, and the retinal tissue was suspended
in 1 mL of 25 mmol/L of
tris(hydroxymethyl)-aminomethane-buffered calcium- and
magnesium-free Hank’s balanced salt solution, pH 7.4,
contain-ing 2 mmol/L of calcium chloride and 1 mmol/L of
magnesium chloride. The retinas from a single
an-imal were pooled, [‘4C]arachidonic acid (20 zmol/
L) was added, and the retinal tissues were incubated
at 37#{176}Cfor 30 minutes (a time by which maximum
prostacyclin production is achieved). The reaction
was terminated by the addition of 2 vol of
chioro-form-methanol (1:2, by volume), and the
metabo-lites were extracted as described by Bligh and Dyer.8
Extracts were dried over anhydrous magnesium
sulfate, evaporated under a stream of nitrogen, and
dissolved in 100 L of chloroform for prostaglandin
analysis by thin-layer chromatography. Thin-layer
chromatography was performed on silica gel G
plates (Anal Tech, Inc, Newark, DE) in an
ethyla-cetate-acetic acid (99:1, by volume) solvent system9
or in the upper phase of
ethylacetate-isooctane-acetic acid-water (90:50:20:100, by volume).’0
Ref-erence prostaglandins (6-keto-prostaglandin-F,a,
[6-keto-PGF,a}, prostaglandin F2a [PGF2a],
pros-taglandin E2, [PGE2J, thromboxane B2,
prostaglan-din D2 [PGD2]) and arachidonic acid were run on
the same plate and were visualized following
expo-sure to iodine vapor. Following radioautography,
the prostaglandin bands were identified by
compar-ing their retention factor values with those of
reference prostaglandin standards. Radiolabeled
bands were scraped into scintillation vials,
ex-tracted with 500 L of methanol, and counted in
an LKB Mini-Beta Counter using Liquiscint. The
counting efficiency in Liquiscint was 94% and 33%
for the ‘4C and 3H labels, respectively. Recovery of
individual prostaglandins determined using
3H-la-beled products was found to be between 95% and
98% for all metabolites. Prostanoid production in
picomoles per milligram of dry tissue weight was
calculated from the specific radioactivity of the
added substrate, and necessary corrections were
-
PGB2
-
PGD2
LEU KOT RIE N ES
and
HETEs Retinal tissues from an additional two control
kittens were preincubated for ten minutes in the presence or absence of 30 .tmol/L indomethacin (a cyclooxygenase inhibitor) or 30 mol/L of
nordihy-droguaiaretic acid (NDGA, a lipoxygenase
inhibi-tor) prior to the addition of [‘4C]arachidonic acid
to ascertain whether the arachidonate metabolites
produced were enzymatic products (Fig 2).
Materials used and their sources were as follows: prostaglandin standards (Upjohn Co, Kalamazoo,
MI), arachidonic acid (purity >99%) (Nu-Chek,
Inc, Elysian, MN), and [‘4C]arachidonic acid (50 to
60 mCi/mmol) and 3H-labeled prostaglandins
(Amersham, Arlington Heights, IL, or New
Eng-land Nuclear, Boston, MA).
Statistical significance was determined by
ran-domized complete block analysis of variance (F
ratio), and individual treatments were compared
with their litter mate controls by the Dunnett’s
test.1’
RESULTS
As shown in Fig 3, in response to exogenous
arachidonic acid, kitten retinal tissues produced
several prostaglandin metabolites, including
6-keto-PGF,. (the end product of prostacyclin
hy-drolysis), PGF2a, PGE2, and thromboxane B2 (the
end product of thromboxane A2) with retention
factor values of 0.08 ± 0.02 (mean ± SD), 0.12 ±
0.02, 0.23 ± 0.04, and 0.3 ± 0.02, respectively, in
the ethylacetate-acetic acid system. The second
thin-layer chromatography system, ie,
ethylacetate-ARACHIDONIC ACID
*
CYCLIC
EN DOPEROX IDES
Isomerase Thromboxone A2
RVJYflSnt<tose
PGE2ond PGF2 PROSTACYCLIN THROMBOXANE A2
6-KETO-PGF1 THROMBOXANE B2
Fig 2. Arachidonic acid metabolism via cyclooxygenase
and lipoxygenases. Enzymatic steps in conversion of
ar-achidonic acid to its various end products is outlined. Indomethacin is an inhibitor of cyclooxygenase, prevent-ing the production from arachidonic acid of metabolites 6-keto-prostaglandin F, (6KETOPGF,), prostaglan-din F2, (PGF2), prostaglandin E2 (PGE2), and
thrombox-ane B2. In contrast, nordihydroguaiaretic acid is an
inhibitor of lipoxygenases. HETES, hydroxyeicosa-tetraenoic acid. Asterisks indicate site of action of indo-methacin (*) and nordihydroguaiaretic acid (**).
-
TXB2
-
PGE
-
PGF2a
-
6KPGF1a
Origin
Fig 3. Thin-layer chromatogram (with ethylacetate-acetic acid system) of arachidonate metabolites produced by normal kitten retina at 1 week of age in response to ‘4C-arachidonic acid. Positions of standards are shown to right of thin-layer chromatography panel. Abbreviations:
AA, arachidonic acid; PGB2, prostaglandin B2; PGD2,
prostaglandin D2; TXB2, thromboxane B2; PGE2, pros-taglandin E2; PGF2, prostaglandin F2; 6KPGF,, 6-ke-toprostaglandin F,.
isooctane-acetic acid-water (which was used to
con-firm the identity of the retinal prostanoids) also
showed the formation of 6-keto-PGF,, PGF2,
PGE2, and thromboxane B2. This latter thin-layer
chromatography system did not resolve PGE2 from
thromboxane B2, however, such that the estimation
of all quantitative metabolite values were calculated from the ethylacetate-acetic acid system. Inhibition
studies with indomethacin and NDGA showed that
all retinal prostanoids were products of vascular
cyclooxygenase, in that the production of
6-keto-PGF,, PGE2, PGE2a, and thromboxane B2 was
abolished by indomethacin but not by pretreatment
with NDGA.
A significant reduction in prostacyclin was
oh-served (Table and Fig 4) when control kittens in
each litter were compared with their hyperoxic and
Thromboxane B2 Total CO Metabolites
* Values are given as picomoles per milligram of dry tissue weight.
(I)
Ui
II
HYPEROXIA CONTROL RECOVERY
TABLE. Cyclooxygenase Metabolites From Individual Experiments
6-Keto-Prostaglandin .
F, Prostagland,n E2 Prostaglandin F2..
Experiment 02 Control Recovery 02 Control Recovery 02 Control Recovery 02 Control Recovery 02 Control Recovery No. Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter Litter
1 1.6 2.5 1.8 0.06 0.05 0.03 1.1 1.49 1.38 2.04 2.0 2.0 4.8 6.0 5.2
2 3.5 3.9 2.6 2.08 2.16 2.4 1.87 1.83 2.31 3.4 3.5 3.9 10.9 11.4 11.2
3 1.5 1.9 2.1 1.05 1.25 1.34 0.84 1.50 0.97 1.4 1.8 1.7 4.8 6.5 6.1
4 1.4 2.5 1.5 5.41 6.45 5.47 1.38 2.63 1.38 3.0 3.7 2.5 11.1 15.3 10.9
5 1.2 1.5 1.4 3.32 3.24 3.16 1.07 1.20 1.22 1.6 1.9 1.7 7.1 7.8 7.5
6 0.4 0.6 0.37 0.27 0.0 0.08 0.1 0.24 0.15 0.8 0.5 0.5 1.5 1.3 1.1
7 0.1 0.4 0.4 0.0 1.41 0.81 0.06 0.46 0.41 0.04 0.1 0.28 0.2 2.3 1.9
8 1.0 2.6 0.2 0.32 0.39 0.32 0.58 1.26 0.38 1.1 1.7 1.3 3.0 6.0 2.2
Fig 4. Effects of hyperoxia on production of 6-keto-prostaglandin F, (6 K PGF,) by retinal tissues. Retinal tissues from control, hyperoxic, or recovery kittens were
incubated with 20 mol/L of ‘4C-arachidonic acid for 30
minutes at 37#{176}Cin 1 mL of
tris(hydroxymethyl)-aminomethane-Hanks’ balanced salt solution, pH 7.4.
Metabolites were extracted and analyzed by thin-layer
chromatography. Connected points represent values for
control
(#{149}),
hyperoxic and recovery (A) kittens from same litter. Values in hyperoxic and recovery groups were significantly different from their litter mate controls by Dunnett’s test at P <.05.previously described. Whereas a 6-keto-PGF1 level
of 1.99 ± 0.41 (mean ± SEM) pmol/mg of dry
retinal tissue weight was measured in control
kit-tens, the values of the litter mate hyperoxic and
recovery animals were 1.34 ± 0.36, and 1.30 ± 0.31
pmol, respectively (P <.05). The decrease in retinal
prostacyclin production was accompanied by a
con-comitant decrease in total retinal cyclooxygenase
metabolite production, with the reduction in total
prostanoids mirroring closely the observed
inhibi-tion in prostacyclin (Table and Fig 5). Whereas a
value for total cyclooxygenase metabolites of 7.08
± 1.61 (mean ± SEM) pmol/mg was produced in
HYPEROXIA CONTROL RECOVERY
Fig 5. Effect of hyperoxia on production of total pros-tanoids by retinal tissues. Retinal tissues from control,
hyperoxic, or recovery kittens were incubated with 20
jmol/L of ‘4C-arachidonic acid for 30 minutes at 37#{176}Cin
1 mL of tris(hydroxymethyl)aminomethane-Hanks’
bal-anced salt solution, pH 7.4. Metabolites were extracted
and analyzed by thin-layer chromatography. Total
pros-tanoid production is sum of 6-keto-prostaglandin F1,
prostaglandin F2a, prostaglandin E2, and thromboxane B2
production. Connected points represent values for control
(#{149}),
hyperoxic (i), and recovery (A) kittens from thesame litter. Hyperoxic and recovery values were signifi-cantly different from their litter mate controls by Dun-nett’s test at P <.05 or P <.01.
control kittens, the values for litter mate hyperoxic
and recovery animals were 5.43 ± 1.43 and 5.76 ±
1.39 pmol, respectively (P <.01 and P <.05).
Al-though values fot retinal thromboxane B2 were
minimally lower in the hyperoxic (1.67 ± 0.39) and
recovery groups (1.74 ± 0.4), they were not
signifi-cantly different from those of the controls (1.9 ±
0.44 pmol). As depicted in Figs 4 and 5, there was
marked interlitter variability in the values for both
retinal 6-keto-PGF,a and total cyclooxygenase
No significant differences in pH and PCo2 have
been observed when arterial blood gases were
com-pared in control and hyperoxic kittens in our other
studies. Kittens in 80% inspired oxygen
demon-strated a pH of 7.45 ± 0.7 (mean ± SD), Pao2 of
305 ± 91 mm Hg, and PCo2 of 26 ± 7 mm Hg. A
pH of 7.45 ± 0.7, Pa02 of 90 ± 26 mm Hg, and
PCo2 of 30 ± 5 mm Hg were measured in control
animals.
DISCUSSION
As shown in Fig 2, arachidonic acid is
metabo-lized via the enzyme cyclooxygenase by vascular
endothelial cells to prostacyclin, a potent
vasodi-lator and platelet antiaggregatory compound that
is in part responsible for the antithrombogenic
po-tential of the vessel wall. Prostacyclin is rapidly
hydrolyzed to 6-keto-PGF,a, which is its stable
metabolite. Other vascular cyclooxygenase products
include PGE2 and PGF2, which are formed from
endoperoxides via the reductase or isomerase
en-zymes. In some species, endothelial cells also
con-tam the enzyme thromboxane synthetase that
con-verts endoperoxide intermediates to the
vasocon-strictor and platelet proaggregatory compound
thromboxane A2. Thromboxane A2 is unstable,
undergoing rapid hydrolysis to thromboxane B2 its
stable metabolite.
We have shown that the microvasculature of the
normal kitten retina at 1 week of age produces the
cyclooxygenase metabolites 6-keto-PGF,a,
throm-boxane B2, PGE2, and PGF2a. In vivo exposure of
newborn animals to hyperoxic conditions (80%
oxy-gen for 48 hours) causes a reduction of
approxi-mately 33% in retinal prostacyclin production in
response to exogenous arachidonate. Litter mates
who were exposed to oxygen for 48 hours and were
then allowed to recover for a day in room air
main-tamed a similar reduction in their retinal
prosta-cyclin values. A reduction in total retinal
prosta-noids that closely paralleled the changes observed
in prostacyclin was seen in both the hyperoxic and
in the recovery animals. Although the results are
statistically significant there was marked interlitter
variability in the values of the cyclooxygenase
prod-ucts. Because maximum intra- and interassay
var-iability were noted to be 8% and 17%, respectively,
the cause for the variability in metabolite
produc-tion appears to reside in other factors. Interlitter
variability could be due to the differences in
post-natal age at which each litter was killed, especially
because retinal vascularity increases rapidly during
the first 4 weeks of postnatal life. Moreover, litters
vary in maturity at birth, and when retinal
perfu-sions are performed in control animals, there is
distinct variability in retinal vascularity between
kittens from the same and from different litters:
The results of the present in vivo study are
consistent with our previous in vitro work. We had
shown that short-term (20 minute) in vitro
expo-sure of umbilical vessels to a 95% oxygen-5%
car-hon dioxide gas mixture caused a 30% inhibition in
the ability of the vessels to produce prostacyclin.7
In the present study, we observed that a nearly
identical effect occurs following the in vivo
expo-sure of retinal microvasculature to hyperoxia of 48
hours’ duration in the newborn kitten model. The
finding that prostacyclin and total prostanoid
formation were inhibited to a similar degree
sug-gests that the effect of oxygen on the microvessels
in vivo occurs at the level of vascular
cyclooxyge-nase. This finding is in keeping with the work of
others’2’4 and with our previous in vitro kinetic
analyses of cyclooxygenase from human umbilical
arteries that were exposed to elevated oxygen
ten-sions.’5 Our previous studies had shown that
de-creased prostacyclin production by hyperoxic tissue
was due to cyclooxygenase inactivation. Although
the maximum rate of conversion of arachidonic acid
to prostanoids was decreased by 30%, the affinity
for arachidonate of the cyclooxygenase enzyme
re-mained unchanged.’5 Our observation that retinal
prostacyclin and total prostanoid formation
re-mains significantly decreased in the recovery
ani-mals who had been placed in room air for 24 hours
following their exposure to hyperoxia suggests the
continued presence of inhibitors of vascular
cy-clooxygenase during the recovery period or a slow
turnover rate of this enzyme in retinal tissues.
Whether a 30% decrease in prostacyclin
forma-tion in the microvasculature can cause
vasoocclu-sion will need further clarification, because no
per-tinent studies have addressed this issue to date.
When compared to the macrovasculature, however,
baseline values for prostacyclin appear to be
de-creased in the microvessels.’6 Thus, although a
30%-decrease in the production of the
antithrom-botic metabolite prostacyclin may not be significant
in large vessels, a similar decrease may be of much
greater importance in vasculature (retinal) in which
baseline production is low.
A role for the metabolites of arachidonic acid in
the pathogenesis of oxygen-induced retinopathy
has been previously suggested. The administration
of the irreversible cyclooxygenase inhibitor aspirin
to oxygen-exposed puppies markedly enhanced the
degree of oxygen-induced retinopathy in a previous
report.’7 In humans, conflicting effects on the
reti-nopathy of prematurity have been attributed to
indomethacin.”.”9 One other animal study has
in response to hyperoxia.2#{176} Beagle puppies were
used, and retinal tissues were assessed for
prosta-noid formation following exposure of the animal
tissues in vitro to various gaseous combinations.
Changes in retinal prostacyclin levels were found
to be randomly distributed and no characteristic
patterns were noted following hyperoxic exposure.
However, puppies of various ages (two to 29 days)
were used with small numbers (n = 2) in each group
studied. In view of the small sample sizes, the
failure to detect significant differences in retinal
prostacyclin is not surprising. In addition, rather
than an in vivo exposure to oxygen as described in
our study, the puppies were initially killed,
follow-ing which their minced retinal tissues were exposed
to in vitro hyperoxia.
During the acute vasoobliterative phase of
oxy-gen-induced retinopathy, the visualized histologic
retinal pathologic changes are compatible with
those expected from local inhibition of endothelial
cell prostacyclin production, ie, vasoconstriction,
thrombus formation, and occlusion of the retinal
vascular lumen. We have demonstrated that
expo-sure of kittens to hyperoxia does lead to alterations in cyclooxygenase activity that result in a reduction
in retinal prostacyclin and total prostanoid
forma-tion. This change is observed acutely in hyperoxia
and also in animals 24 hours into a room air
recov-ery period following their hyperoxic insult. The
data suggests that inhibition of the potent
vasodi-lator and antithrombotic metabolite prostacyclin
plays a role in the acute vasoobliterative phase of
oxygen-induced retinopathy in the animal model.
ACKNOWLEDGMENTS
This work was supported by Public Health Service
grant EY-05614 from the National Institutes of Health.
The authors thank Carolyn Ganley for technical
as-sistance and Nancy Bovalino for secretarial support.
REFERENCES
1. Kinsey VE, Arnold HJ, Kalina RE, et a!: Pao2 levels and retrolental fibroplasia: A report of the cooperative study. Pediatrics 1977;60:655
2. Lucey JF, Dangman B: A reexamination ofthe role of oxygen in retrolental fibroplasia. Pediatrics 1984;73:82-96
3. Kinsey VE: Cooperative study of retrolental fibroplasia and the use of oxygen. Ophthalmology 1956;56:481
4. Ashton A, Ward B, Serpell G: Role of oxygen in the genesis of retrolental fibroplasia: A preliminary report. Br J Ophthalmol 1953;37:513
5. Ashton A, Blach R: Studies on developing retinal vessels. Effecta of oxygen in the retinal vessels of the ratling. Br J Ophthalrnol 1961;45:321
6. Moncada 5, Vane JR: Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N Engl J Med 1979;300:1142
7. Stuart MJ, Setty BNY, Walenga RW, et al: Effects of hyperoxia and hypoxia on vascular prostacyclin formation in vitro. Pediatrics 1984;74:548-553
8. Bligh EG, Dyer WJ: A rapid method oftotal lipid extraction. Can J Biochem Physiol 1959;37:911
9. Vanderhoek JY, Feinstein MB: Local anesthetics, chlorpro-mazine and propranolol inhibit stimulus-activation of phos-pholipase A2 in human platelets. MolPharmacol 1979;16:171 10. Lapetina EG, Cuatrecasas P: Stimulation of phosphatidic
acid production in platelets proceeds the formation of ar-achidonate and parallels the release of 5HT. Biochim Bio-phys Acta 1979;573:394
11. Steel RGD, and Torrie JH: Principles and Procedures of Statistics, ed 2. New York, McGraw Hill, 1970, p 188 12. Smith WL, Lands WEM: Oxygenation of polyunsaturated
fatty acids during prostaglandin biosynthesis by sheep ye-sicular glands. Biochemistry 1972;11:3276
13. Lands WEM, Sauter J, Stone GW: Oxygen requirement for prostaglandin biosynthesis. Prostaglandins Med 1978;1:117 14. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen
rad-icals, transition metals and disease. Biochem J 1984;219:1 15. Setty BNY, Walenga RW, Stuart MJ: Kinetic analyses of
the effects of hyperoxia and hypoxia on vascular cyclooxy-genase activity in vitro. Biochem Biophys Res Commun 1984;125:170
16. Charo IF, Shak 5, Karasek MA, et a!: Prostaglandin 12 is not a major metabolite of arachidonic acid in cultured endo-thelial cells from human foreskin microvessels. J Clin Invest 1984;74:914
17. Flower RW, Blake DA: Retrolental fibroplasia: Evidence for a role ofthe prostaglandin cascade. Pediatr Res 1981;15:1293 18. Sun 5, Aranda Z, Vangvanichyakorn K: Indocin and
reti-nopathy of prematurity (ROP), abstracted. Pediatr Res 1982;16:107
19. Procianoy RS, Garcia-Prats, JA, Hittner HM, et a!: Use of indomethacin and its relationship to retinopathy of prema-turity in very low birth weight infants. Arch Dis Child 1980;55:362